Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2011465
Max Phase: Preclinical
Molecular Formula: C46H60N8O7
Molecular Weight: 837.03
Molecule Type: Protein
Associated Items:
ID: ALA2011465
Max Phase: Preclinical
Molecular Formula: C46H60N8O7
Molecular Weight: 837.03
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@H](CCCCN)N(C)C(=O)[C@@H](Cc2c[nH]c3ccccc23)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O
Standard InChI: InChI=1S/C46H60N8O7/c1-28(2)40-43(58)50-36(24-30-14-8-7-9-15-30)44(59)52(4)29(3)41(56)49-37(25-31-19-21-33(55)22-20-31)45(60)54(6)39(26-32-27-48-35-17-11-10-16-34(32)35)46(61)53(5)38(42(57)51-40)18-12-13-23-47/h7-11,14-17,19-22,27-29,36-40,48,55H,12-13,18,23-26,47H2,1-6H3,(H,49,56)(H,50,58)(H,51,57)/t29-,36-,37-,38-,39+,40-/m0/s1
Standard InChI Key: HIPRHTXZCPIYPG-UNNGUJMWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 837.03 | Molecular Weight (Monoisotopic): 836.4585 | AlogP: 2.66 | #Rotatable Bonds: 11 |
Polar Surface Area: 210.27 | Molecular Species: BASE | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.40 | CX Basic pKa: 10.16 | CX LogP: 2.07 | CX LogD: 0.50 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.12 | Np Likeness Score: 1.01 |
1. Chatterjee J, Laufer B, Beck JG, Helyes Z, Pintér E, Szolcsányi J, Horvath A, Mandl J, Reubi JC, Kéri G, Kessler H.. (2011) N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation., 2 (7): [PMID:24900340] [10.1021/ml200032v] |
Source(1):